Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancer. (2020)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41388-020-1210-y
PubMed Identifier: 32066877
Publication URI: http://europepmc.org/abstract/MED/32066877
Type: Journal Article/Review
Volume: 39
Parent Publication: Oncogene
Issue: 15
ISSN: 0950-9232